SUMMARy Recent evidence suggests that using intravenous isotonic albumin solution for haemodynamic resuscitation in neurotrauma is associated with adverse outcomes. This study assessed the correlations between cerebrospinal fluid protein concentrations, serum albumin concentrations and intracranial pressure in a cohort of neurosurgical patients. After obtaining ethics committee approval, correlations between concomitant cerebrospinal fluid protein concentrations, serum albumin concentrations and the mean daily intracranial pressure of 63 consecutive neurosurgical patients, grouped as neurotrauma or intracranial haemorrhage, admitted between 1 January and 31 December 2007, were assessed. The mean daily intracranial pressure was significantly associated with cerebrospinal fluid protein concentrations (Spearman correlation coefficient [SCC]=0.496, P=0.001), white cell counts (SCC=0.359, P=0.001), red cell counts (SCC=0.399, P=0.001) and serum albumin concentrations (SCC=0.431, P=0.001) in patients with neurotrauma (n=23). Cerebrospinal fluid protein concentrations were also significantly associated with concomitant serum albumin concentrations (SCC=0.393, P=0.001) in these patients. In patients with intracranial haemorrhage (n=40), the mean daily intracranial pressure was only significantly associated with cerebrospinal fluid white cell and red cell counts but not cerebrospinal fluid protein and serum albumin concentrations. In summary, intracranial pressure is correlated with cerebrospinal fluid protein and serum albumin concentrations in patients with severe neurotrauma, and these suggest that blood-brain barrier may not be completely intact after severe neurotrauma.
after severe neurotrauma, it is possible that serum albumin may leak into the extracellular fluid of the brain resulting in more brain oedema 12 . We hypothesised that the BBB may not be intact and serum albumin concentrations may be associated with CSF protein concentrations and intracranial pressure (ICP) after neurotrauma and intracranial haemorrhage. In this study we assessed the correlations between CSF protein concentrations, serum albumin concentrations and ICP in a cohort of patients with severe neurotrauma and intracranial haemorrhage.
MATERIALS AND METHoDS
After obtaining hospital ethics approval, the laboratory and clinical data of 63 consecutive neurosurgical patients admitted to the intensive care unit (ICU) of Royal Perth Hospital in Western Australia between 1 January and 31 December 2007 were retrieved from the laboratory and ICU clinical databases. All study patients had an external ventricular drain in situ for clinical reasons, as part of the usual management protocol, to measure and control their ICP during their stay in the ICU. The ICU protocol aimed to maintain adequate sedation, normocapnia (30 to 40 mmHg), normglycaemia (6 to 8 mmol/l), serum sodium between 145 and 150 mmol/l, euvolaemia (central venous pressure between 10 to 15 mmHg and a neutral daily fluid balance) and a cerebral perfusion pressure greater than 60 mmHg for all patients who were at risk of intracranial hypertension.
The laboratory and clinical data assessed included the mean daily intracranial pressure (average of hourly ICP over a 24 hour period), daily serum albumin and total protein concentrations, CSF protein concentrations, CSF white and red blood cell counts, use of intravenous albumin solution, admission and worst first 24 hour Glasgow Coma Scale (GCS) score, Acute Physiology and Chronic Health Evaluation II score and its derived predicted mortality 13 , length of ICU and hospital stay and hospital mortality. The serum albumin (reference range, 35 to 50 g/l) and CSF protein (reference range, 0.15 to 0.45 g/l) concentrations were measured by Bromocresol Green reagent and turbidimetric immunoassay technique (Abbott Architect ® c16000 automated analyser), respectively. CSF albumin was not available for analysis in this study because it was not routinely measured.
Statistical analyses
Continuous variables were analysed by Student's t-test. Categorical variables and continuous variables with skewed distribution (i.e. standard deviation greater than 50% of the mean) were analysed by chisquare and Mann-Whitney test, respectively. The associations between the mean daily ICP and CSF protein concentrations, CSF white and red blood cell counts or serum albumin concentrations were assessed by non-parametric Spearman correlation coefficient (SCC). The relationship between mean daily ICP and serum albumin concentrations was further assessed by a scatter plot and modelled by either a linear or quadratic equation. The patients were grouped into either neurotrauma or intracranial haemorrhage (subarachnoid or intracerebral haemorrhage) as an a priori designation during these analyses to assess whether the relationship between ICP and serum albumin concentrations was different between these two groups of patients. All analyses were performed by SPSS software for Windows (version 13.0, 2005, Chicago, IL, USA) and a P <0.05 was regarded as significant. No correction was used for multiple comparisons in the analyses.
RESULTS
A total of 63 consecutive neurosurgical patients with an external ventricular drain, admitted between 1 January and 31 December 2007, were studied. Among these 63 patients, 23 (36.5%) had neurotrauma, 29 (46%) had subarachnoid haemorrhage and 11 (17.5%) had intracerebral haemorrhage. The median number of days of requiring an external ventricular drain was eight days (standard deviation 4.6, interquartile range 5 to 10). The patients with neurotrauma were significantly younger, more likely to be male, associated with a higher mean daily ICP (13.6 vs 11.7), had a lower GCS on admission to the ICU (mean GCS 5.3 vs 8.7), and a longer length of ICU stay (11.7 vs 8.0 days) when compared to the patients with either subarachnoid or intracerebral haemorrhage ( Table  1 ). The CSF white and red blood cell counts of the neurotrauma patients were lower than those with intracranial haemorrhage (Table 1) . Although the crude CSF protein concentrations of the neurotrauma patients were lower than the intracranial haemorrhage group, this difference was reversed after the CSF protein concentrations were corrected for CSF red blood cells (Table 1) .
In patients with neurotrauma, the mean daily ICP was significantly associated with the CSF protein concentrations (SCC=0.496, P=0.001), white cell and red blood cell counts and also serum albumin concentrations (SCC=0.431, P=0.001) ( between mean daily ICP and serum albumin concentrations appeared to follow a quadratic relationship (R 2 =0.209, intracranial pressure= -19.8 + 1.75 × albumin concentration -0.021 ×albumin concentration 2 (Figure 1 ). CSF protein concentrations were also significantly associated with serum albumin concentrations (SCC=0.393, P=0.001).
In patients with subarachnoid or intracerebral haemorrhage, the mean daily ICP was only significantly associated with the CSF white cell and red cell counts but not the serum albumin concentrations (Table 2) ( Figure 2 ). CSF protein concentrations were also not associated with the serum albumin concentrations in these patients (SCC=-0.018, P=0.751).
DISCUSSIoN
This study showed that mean daily intracranial pressure was associated with serum albumin concentrations, CSF protein concentrations, and CSF white and red blood cell counts in patients with severe neurotrauma. The mean daily ICP was, however, only associated with CSF white and red blood cell counts in patients with intracranial haemorrhage. Evidence suggests that excessive extracellular fluid is a major contributing factor to brain swelling in traumatic brain injuries 14 . However, whether BBB dysfunction contributes to the accumulation of excessive extracellular fluid after severe neurotrauma remains controversial 5 . Albumin accounts for over 50% of all CSF proteins in many neurological diseases including neurotrauma 15 . Some animal and human studies have shown that BBB may not be completely intact 8, 9 , and serum albumin may accumulate in the extracellular fluid of the brain after severe neurotrauma 13, 17 . on the contrary, some animal studies have shown that cytotoxic oedema is more important than vasogenic oedema and BBB dysfunction is not always observed after severe neurotrauma 17 . The correlations between mean daily ICP, serum albumin and CSF protein concentrations in our neurotrauma patients suggest that BBB dysfunction and vasogenic oedema may contribute, in part, to the brain oedema after severe neurotrauma. our results provide one possible explanation, in addition to those outlined by Grände 5 , for the association between intravenous albumin and poor neurological outcomes reported by Myburgh et al in the SAFE-TBI study 6 . Although intravenous albumin, as part of the 'Lund concept' treatment strategy, has been shown to reduce mortality of neurotrauma in one study 4 , a subsequent study from the same institution has also reported an increase in the number of patients with moderate disabilities 18 . Some observational studies showed that low serum albumin concentrations were associated with unfavourable neurological outcomes 19 , but this association could also be explained by the effect of residual confounding 20 .
Intravenous albumin is expensive and the duration or extent of BBB dysfunction after severe neurotrauma can be highly variable 8, 9, 21, 22 . As such, our results suggested that it might be prudent to avoid using intravenous albumin as a standard resuscitation fluid immediately after severe neurotrauma until its safety and cost-effectiveness can be established by an adequately powered randomised controlled trial 16, 22, 23 .
our results showed that ICP was significantly related to the CSF red and white blood counts, but not CSF protein or serum albumin concentrations, in patients with subarachnoid or intracerebral haemorrhage. Evidence suggests that cytotoxic oedema plays a significant role in the pathogenesis of brain oedema in the animal models of intracerebral or subarachnoid haemorrhage [24] [25] [26] . High doses of intravenous albumin have also been reported to be useful in reducing cytotoxic cerebral oedema in animal models of cerebrovascular occlusion 27, 28 and a small clinical study on intracerebral haemorrhage 29 . our findings were consistent with these studies and suggested that the BBB may be grossly intact in these patients. Large randomised controlled studies are, however, needed to determine whether intravenous albumin is safe and can improve patient-centred outcomes in acute cerebrovascular diseases.
This study has some limitations. First, the correlation (r 2 =0.205) between ICP and serum albumin concentrations in our neurotrauma patients was weak. Second, cerebral perfusion pressure 5, 30 , intravascular volume 31 and CSF drainage 9,32 may also affect the relationships between serum albumin, CSF protein and ICP after severe neurotrauma. The potential interactions between these variables have not been thoroughly studied, but they merit further investigation. Finally, we did not have data on the CSF albumin concentrations in our patients. Whether albumin constituted a large proportion of the CSF protein in our patients remains uncertain, but this merits further investigation in a prospective study.
In summary, this clinical study showed that mean daily ICP was correlated with serum albumin and CSF protein concentrations and this suggested that BBB might not be completely intact in some patients after severe neurotrauma. An increase in permeability of the BBB after severe neurotrauma may explain why liberal use of intravenous albumin, as a standard resuscitation fluid, might be potentially harmful.
